45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
20,416
Insurances with rates
21
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 36110196 | HC ELTRD/INSERT PACE-DEFIB | $75,840 | $41,712 | — | — | 20 |
| 36110196 | HC ELTRD/INSERT PACE-DEFIB | $75,840 | $41,712 | — | — | 29 |
| 36012009 | HC RMV&RPLC ICD GEN MULT LEAD SYST | $72,072 | $39,640 | — | — | 20 |
| 36012009 | HC RMV&RPLC ICD GEN MULT LEAD SYST | $72,072 | $39,640 | — | — | 29 |
| 36012008 | HC RMV&RPLC ICD GEN DUAL LEAD SYST | $70,528 | $38,790 | — | — | 20 |
| 36012008 | HC RMV&RPLC ICD GEN DUAL LEAD SYST | $70,528 | $38,790 | — | — | 29 |
| 36012007 | HC RMV&RPLC ICD GEN SING LEAD SYST | $67,367 | $37,052 | — | — | 20 |
| 36012007 | HC RMV&RPLC ICD GEN SING LEAD SYST | $67,367 | $37,052 | — | — | 29 |
| 36111228 | HC INS/REP SUBQ DEFIBRILLATOR INCLUDING EVAL WHEN PERFORMED | $60,109 | $33,060 | — | — | 20 |
| 36111228 | HC INS/REP SUBQ DEFIBRILLATOR INCLUDING EVAL WHEN PERFORMED | $60,109 | $33,060 | — | — | 29 |
| RX-184497 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $58,686 | $32,278 | — | — | 20 |
| RX-184497 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $58,686 | $32,278 | — | — | 29 |
| 36012006 | HC INS ICD GEN ONLY W EXIST MULT LDS | $54,776 | $30,127 | — | — | 20 |
| 36012006 | HC INS ICD GEN ONLY W EXIST MULT LDS | $54,776 | $30,127 | — | — | 29 |
| 36110193 | HC INSERT PULSE GENERATOR | $51,613 | $28,387 | — | — | 20 |
| 36110193 | HC INSERT PULSE GENERATOR | $51,613 | $28,387 | — | — | 29 |
| 36110187 | HC L VENTRIC PACING LEAD ADD-ON | $43,865 | $24,126 | — | — | 20 |
| 36110187 | HC L VENTRIC PACING LEAD ADD-ON | $43,865 | $24,126 | — | — | 29 |
| RX-183853 | LUSPATERCEPT-AAMT 75 MG SUBQ SOLR | $40,905 | $22,498 | — | — | 20 |
| RX-183853 | LUSPATERCEPT-AAMT 75 MG SUBQ SOLR | $40,905 | $22,498 | — | — | 29 |
| 36110200 | HC ENDOVASC TAA REPR INCL SUBCL | $40,756 | $22,416 | — | — | 20 |
| 36110200 | HC ENDOVASC TAA REPR INCL SUBCL | $40,756 | $22,416 | — | — | 29 |
| SUP-74021165 | JRNY II CR FEM OX NP LT SZ 5 | $39,970 | $21,984 | — | — | 20 |
| SUP-74021165 | JRNY II CR FEM OX NP LT SZ 5 | $39,970 | $21,984 | — | — | 29 |
| 48110004 | HC EVASC RPR A-AO NDGFT | $36,770 | $20,224 | — | — | 20 |
| 48110004 | HC EVASC RPR A-AO NDGFT | $36,770 | $20,224 | — | — | 29 |
| 36110503 | HC FEM/POPL REVASC STNT & ATHER | $34,699 | $19,084 | — | — | 20 |
| 36110503 | HC FEM/POPL REVASC STNT & ATHER | $34,699 | $19,084 | — | — | 29 |
| 36110362 | HC ENDOVASC TAA REPR W/O SUBCL | $32,775 | $18,026 | — | — | 20 |
| 36110362 | HC ENDOVASC TAA REPR W/O SUBCL | $32,775 | $18,026 | — | — | 29 |
| 36110502 | HC FEM/POPL REVASC W/STENT | $31,181 | $17,150 | — | — | 20 |
| 36110502 | HC FEM/POPL REVASC W/STENT | $31,181 | $17,150 | — | — | 29 |
| 36110498 | HC ILIAC REVASC W/STENT ADD-ON | $31,181 | $17,150 | — | — | 20 |
| 36110498 | HC ILIAC REVASC W/STENT ADD-ON | $31,181 | $17,150 | — | — | 29 |
| 36110496 | HC ILIAC REVASC W/STENT | $31,166 | $17,141 | — | — | 20 |
| 36110496 | HC ILIAC REVASC W/STENT | $31,166 | $17,141 | — | — | 29 |
| SUP-150440207 | ATTUNE CRS FEMORAL RT SZ7 CEM | $30,648 | $16,856 | — | — | 20 |
| SUP-150440207 | ATTUNE CRS FEMORAL RT SZ7 CEM | $30,648 | $16,856 | — | — | 29 |
| RX-148911 | VEDOLIZUMAB 300 MG IV SOLR | $29,895 | $16,442 | — | — | 20 |
| RX-148911 | VEDOLIZUMAB 300 MG IV SOLR | $29,895 | $16,442 | — | — | 29 |
| RX-169866 | OCRELIZUMAB 300 MG/10ML IV SOLN | $29,202 | $16,061 | — | — | 20 |
| RX-169866 | OCRELIZUMAB 300 MG/10ML IV SOLN | $29,202 | $16,061 | — | — | 29 |
| 36110506 | HC TIB/PER REVASC W/STENT | $28,316 | $15,574 | — | — | 20 |
| 36110506 | HC TIB/PER REVASC W/STENT | $28,316 | $15,574 | — | — | 29 |
| 36012004 | HC RMV&RPLC PCMK GEN MULT LEAD SYS | $28,202 | $15,511 | — | — | 20 |
| 36012004 | HC RMV&RPLC PCMK GEN MULT LEAD SYS | $28,202 | $15,511 | — | — | 29 |
| RX-9002 | ALTEPLASE 100 MG IV SOLR | $27,971 | $15,384 | — | — | 20 |
| RX-9002 | ALTEPLASE 100 MG IV SOLR | $27,971 | $15,384 | — | — | 29 |
| 48110017 | HC REVASC ACUTE MI W DES/ATHERECTOMY/PCTA SINGLE | $27,777 | $15,277 | — | — | 20 |
| 48110017 | HC REVASC ACUTE MI W DES/ATHERECTOMY/PCTA SINGLE | $27,777 | $15,277 | — | — | 29 |
Showing top 50 of 20,416 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.